178 related articles for article (PubMed ID: 10583229)
1. Bcl10 in chronic lymphocytic leukaemia and T-cell prolymphocytic leukaemia.
Yuille MR; Stone JG; Bradshaw PS; Houlston RS
Br J Haematol; 1999 Nov; 107(2):384-5. PubMed ID: 10583229
[TBL] [Abstract][Full Text] [Related]
2. Screening for mutations of Bcl10 in leukaemia.
Grimwade D; Du MQ; Langabeer S; Rogers J; Solomon E
Br J Haematol; 2000 Jun; 109(3):611-5. PubMed ID: 10886211
[TBL] [Abstract][Full Text] [Related]
3. BCL10 gene mutations rarely occur in lymphoid malignancies.
Luminari S; Intini D; Baldini L; Berti E; Bertoni F; Zucca E; Cro L; Maiolo AT; Cavalli F; Neri A
Leukemia; 2000 May; 14(5):905-8. PubMed ID: 10803524
[TBL] [Abstract][Full Text] [Related]
4. Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia.
Langabeer SE; Quinn F; O'Brien D; McElligott AM; Kelly J; Browne PV; Vandenberghe E
Leuk Res; 2012 Apr; 36(4):483-4. PubMed ID: 22230299
[TBL] [Abstract][Full Text] [Related]
5. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
6. Lack of BCL10 mRNA mutation in lymphold malignancies.
Kawano T; Iwase S; Nakayama R; Horiguchi-Yamada J; Kobayashi M; Yamada H
Anticancer Res; 2002; 22(1A):305-9. PubMed ID: 12017308
[TBL] [Abstract][Full Text] [Related]
7. High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia.
Burger H; Nooter K; Sonneveld P; Van Wingerden KE; Zaman GJ; Stoter G
Br J Haematol; 1994 Oct; 88(2):348-56. PubMed ID: 7803281
[TBL] [Abstract][Full Text] [Related]
8. Deletions of D13S25, D13S319 and RB-1 mapping to 13q14.3 in T-cell prolymphocytic leukaemia.
Brito-Babapulle V; Baou M; Matutes E; Morilla R; Atkinson S; Catovsky D
Br J Haematol; 2001 Aug; 114(2):327-32. PubMed ID: 11529851
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the BCL10 gene are not associated with the blast crisis of chronic myeloid leukaemia.
Bose S; Goldman JM; Melo JV
Leukemia; 1999 Nov; 13(11):1894-6. PubMed ID: 10557068
[No Abstract] [Full Text] [Related]
10. p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndrome.
Brito-Babapulle V; Hamoudi R; Matutes E; Watson S; Kaczmarek P; Maljaie H; Catovsky D
Br J Haematol; 2000 Jul; 110(1):180-7. PubMed ID: 10930996
[TBL] [Abstract][Full Text] [Related]
11. BCL10 deletions in haematological malignancies: a cloning artefact?
Duke V; Kapoor A; Gricks C; Melo J; Foroni L
Br J Haematol; 2000 Dec; 111(4):1106-8. PubMed ID: 11167747
[TBL] [Abstract][Full Text] [Related]
12. p53 abnormalities in B-cell prolymphocytic leukemia.
Lens D; De Schouwer PJ; Hamoudi RA; Abdul-Rauf M; Farahat N; Matutes E; Crook T; Dyer MJ; Catovsky D
Blood; 1997 Mar; 89(6):2015-23. PubMed ID: 9058723
[TBL] [Abstract][Full Text] [Related]
13. Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.
Takahashi H; Hosokawa Y; Suzuki R; Morishima Y; Nakamura S; Seto M
Jpn J Cancer Res; 1999 Dec; 90(12):1316-20. PubMed ID: 10665648
[TBL] [Abstract][Full Text] [Related]
14. BCL10 somatic mutations rarely occur in gastric lymphoma: detection of high frequency of polymorphisms in BCL10 coding region.
Chen YW; Wong KY; Au WY; Liang RH; Srivastava G
Cancer Genet Cytogenet; 2001 Jun; 127(2):184-7. PubMed ID: 11425462
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of Novel
Kanagal-Shamanna R; Bao H; Kearney H; Smoley S; Tang Z; Luthra R; Yang H; Zhang S; Lin P; Wu D; Medeiros LJ; Lu X
Leuk Lymphoma; 2022 Apr; 63(4):865-875. PubMed ID: 34898335
[No Abstract] [Full Text] [Related]
16. Cytogenetic studies in chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia: a progress report.
Han T; Sadamori N; Block AM; Xiao H; Henderson ES; Emrich L; Sandberg AA
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):393-5. PubMed ID: 3222149
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
Chow KU; Kim SZ; von Neuhoff N; Schlegelberger B; Stilgenbauer S; Wunderle L; Cordes HJ; Bergmann L
Eur J Haematol; 2011 Nov; 87(5):426-33. PubMed ID: 21749447
[TBL] [Abstract][Full Text] [Related]
18. Absence of Bcl10 gene mutations in Ewing's sarcomas.
Park YK; Chi SG; Unni KK
Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
[TBL] [Abstract][Full Text] [Related]
19. Methylation status of the 3rd exon of the c-MYC oncogene in B-cell malignancies.
Crossen PE; Morrison MJ
Leuk Res; 1999 Mar; 23(3):251-3. PubMed ID: 10071077
[TBL] [Abstract][Full Text] [Related]
20. Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphoma.
Tadokoro J; Nakamura Y; Furusawa S; Mitani K
Int J Hematol; 2001 Feb; 73(2):222-5. PubMed ID: 11372735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
